Patents by Inventor Suzanne Zebedee

Suzanne Zebedee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for detecting NANBV associated seroconversion
    Patent number: 7863008
    Abstract: The present invention relates to recombinant expression vectors which express segments of deoxyribonucleic acid that encode recombinant HIV and HCV antigens. These recombinant expression vectors are transformed into host cells and used in a method to express large quantities of these antigens. The invention also provides compositions containing certain of the isolated antigens, diagnostic systems containing these antigens and methods of assaying body fluids to detect the presence of antibodies against the antigens of the invention.
    Type: Grant
    Filed: March 14, 2008
    Date of Patent: January 4, 2011
    Assignees: Bioprocess Pty Ltd., P. Hoffmann-La Roche, Ltd.
    Inventors: Suzanne Zebedee, Genevieve Inchauspe, Marc S. Nasoff, Alfred M Prince
  • Method for detecting nanbv associated seroconversion
    Publication number: 20090155772
    Abstract: The present invention relates to recombinant expression vectors which express segments of deoxyribonucleic acid that encode recombinant HIV and HCV antigens. These recombinant expression vectors are transformed into host cells and used in a method to express large quantities of these antigens. The invention also provides compositions containing certain of the isolated antigens, diagnostic systems containing these antigens and methods of assaying body fluids to detect the presence of antibodies against the antigens of the invention.
    Type: Application
    Filed: January 29, 2009
    Publication date: June 18, 2009
    Inventors: Suzanne Zebedee, Genevieve Inchauspe, Marc S. Nasoff, Alfred M. Prince
  • Methods and systems for producing recombinant viral antigens
    Publication number: 20080193920
    Abstract: The present invention relates to recombinant expression vectors which express segments of deoxyribonucleic acid that encode recombinant HIV and HCV antigens. These recombinant expression vectors are transformed into host cells and used in a method to express large quantities of these antigens. The invention also provides compositions containing certain of the isolated antigens, diagnostic systems containing these antigens and methods of assaying body fluids to detect the presence of antibodies against the antigens of the invention.
    Type: Application
    Filed: March 14, 2008
    Publication date: August 14, 2008
    Inventors: Suzanne Zebedee, Genevieve Inchauspe, Marc S. Nasoff, Alfred M. Prince
  • Methods and systems for producing recombinant viral antigens
    Publication number: 20040214163
    Abstract: The present invention relates to recombinant expression vectors which express segments of deoxyribonucleic acid that encode recombinant HIV and HCV antigens. These recombinant expression vectors are transformed into host cells and used in a method to express large quantities of these antigens. The invention also provides compositions containing certain of the isolated antigens, diagnostic systems containing these antigens and methods of assaying body fluids to detect the presence of antibodies against the antigens of the invention.
    Type: Application
    Filed: October 1, 2003
    Publication date: October 28, 2004
    Inventors: Suzanne Zebedee, Genevieve Inchauspe, Marc S. Nasoff, Alfred M. Prince, Torsten B. Helting, Michael F. Nunn
  • Methods and systems for producing recombinant viral antigens
    Patent number: 6692751
    Abstract: The present invention relates to recombinant expression vectors which express segments of deoxyribonucleic acid that encode recombinant HIV and HCV antigens. These recombinant expression vectors are transformed into host cells and used in a method to express large quantities of these antigens. The invention also provides compositions containing certain of the isolated antigens., diagnostic systems containing these antigens and methods of assaying body fluids to detect the presence of antibodies against the antigens of the invention.
    Type: Grant
    Filed: September 16, 1997
    Date of Patent: February 17, 2004
    Assignees: New York Blood Center
    Inventors: Suzanne Zebedee, Genevieve Inchauspe, Marc S. Nasoff, Alfred S. Prince, Torsten B. Helting, Michael F. Nunn